TCL Archive Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting June 20, 1986
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Cancer Statistics: Colorectal Cancer Incidence Declines, Annual Report Finds May 19, 2000
